医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
27期
74-75
,共2页
张奇峰%钟志雄%李斌%李存仁%刘志东%张鹏飞
張奇峰%鐘誌雄%李斌%李存仁%劉誌東%張鵬飛
장기봉%종지웅%리빈%리존인%류지동%장붕비
心血管病学%心脏再同步化治疗%心力衰竭%三腔起搏器
心血管病學%心髒再同步化治療%心力衰竭%三腔起搏器
심혈관병학%심장재동보화치료%심력쇠갈%삼강기박기
cardiac resynchronization therapy%heart failure
目的探讨心脏再同步化治疗(CRT)对慢性心力衰竭的临床疗效。方法46例慢性心力衰竭患者行双心室再同步化起搏治疗。术后随访30±5个月,观察患者的NYHA心功能分级,QRS时限,左心室射血分数(LVEF),左心室舒张末内径(LVDd)的变化。结果46例患者顺利完成CRT植入术,46例患者NYHA心功能分级由术前4级改善为1-2级, QRS时限由术151.0±11.5ms减少到120.2±3.7ms,左心室射血分数由术前0.29±0.04增加到0.49±0.07;左心室舒张末内径由术前70.9±8.4mm减少到52.0±6.8mm, P<0.01。结论 CRT结合药物治疗可显著改善慢性心力衰竭患者的心功能和临床症状,提高患者的生活质量。
目的探討心髒再同步化治療(CRT)對慢性心力衰竭的臨床療效。方法46例慢性心力衰竭患者行雙心室再同步化起搏治療。術後隨訪30±5箇月,觀察患者的NYHA心功能分級,QRS時限,左心室射血分數(LVEF),左心室舒張末內徑(LVDd)的變化。結果46例患者順利完成CRT植入術,46例患者NYHA心功能分級由術前4級改善為1-2級, QRS時限由術151.0±11.5ms減少到120.2±3.7ms,左心室射血分數由術前0.29±0.04增加到0.49±0.07;左心室舒張末內徑由術前70.9±8.4mm減少到52.0±6.8mm, P<0.01。結論 CRT結閤藥物治療可顯著改善慢性心力衰竭患者的心功能和臨床癥狀,提高患者的生活質量。
목적탐토심장재동보화치료(CRT)대만성심력쇠갈적림상료효。방법46례만성심력쇠갈환자행쌍심실재동보화기박치료。술후수방30±5개월,관찰환자적NYHA심공능분급,QRS시한,좌심실사혈분수(LVEF),좌심실서장말내경(LVDd)적변화。결과46례환자순리완성CRT식입술,46례환자NYHA심공능분급유술전4급개선위1-2급, QRS시한유술151.0±11.5ms감소도120.2±3.7ms,좌심실사혈분수유술전0.29±0.04증가도0.49±0.07;좌심실서장말내경유술전70.9±8.4mm감소도52.0±6.8mm, P<0.01。결론 CRT결합약물치료가현저개선만성심력쇠갈환자적심공능화림상증상,제고환자적생활질량。
Objective: To appraise the therapeutic effects of resynchronous biventricular pacing on refractory chronic heart failure.Methods:46 patients with chronic refractory heart failure accompanied by intraventricular conduction delay were selected to receive resynchronous biventricular pacing. Changes of NYHA functional class, QRS duration, left ventricular ejection fraction (LVEF),left ventricular end diastolic diameter(LVEDD) were observed before and after packer implantation. Results: after implantation, NYHA functional class was obviously improved.QRS duration was obviously decreased to 120.2±3.7ms from 151.0±11.5ms. LVEF was obviously increased to 0.49±0.07 from 0.29±0.04. LVEDD was decreased to 52.0±6.8mm from 70.9±8.4mm. Conclusion: Resynchronous biventricular pacing can improve hemodynamics, cardiac function, clinical symptoms and quality of life in patients with chronic refractory heart failure.